Evidence map›Paper›PMID 37477413›Full record

ArticleFaraday discussions2023

Primary

Bria Garcia, Jessica Sampson, Mary P Watson, Dipannita Kalyani

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Faraday discussions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bria GarciaDepartment of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, USA. mpwatson@udel.edu.ORCID http://orcid.org/0000-0002-4228-3585
Jessica SampsonHigh Throughput Experimentation Facility, Department of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, USA.
Mary P WatsonDepartment of Chemistry & Biochemistry, University of Delaware, Newark, Delaware 19716, USA. mpwatson@udel.edu.ORCID http://orcid.org/0000-0002-1879-5257
Dipannita KalyaniDiscovery Chemistry, Merck & Co., Inc., Kenilworth, New Jersey 07033, USA. dipannita.kalyani@merck.com.ORCID http://orcid.org/0000-0003-4349-8016
University of Delaware · USMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

This renovation project will create over 1455 sq. ft. of state- of-the-art reseaP20GM104316 · NIGMS · UNIVERSITY OF DELAWARE · PI FOX, JOSEPH M · 2014 to 2024
$26.8M
Supplement to Harnessing Alkyl Amines and Alkyl Alcohols in Cross-CouplingR35GM131816 · NIGMS · UNIVERSITY OF DELAWARE · PI Mary P Watson · 2019 to 2026
$3.4M
Molecular Design of Advanced BiomaterialsP20GM103541 · NIGMS · UNIVERSITY OF DELAWARE · PI POLENOVA, TATYANA · 2012 to 2012
$2.1M
Q-Exactive Orbitrap LC-MC/MS SystemS10OD016267 · OD · UNIVERSITY OF DELAWARE · PI JOHNSTON, MURRAY V · 2013 to 2013
$573k
NIGMS NIH HHS P20 GM103541NIGMS NIH HHS P20 GM104316NIGMS NIH HHS R35 GM131816NIH HHS S10 OD016267
6 · The paper itself

Abstract

This report details a systematic comparison of the scope of aryl bromides in nickel-catalyzed, reductive cross-electrophile couplings of primary

Identifiers

PMID37477413
PMCPMC10799965
OpenAlexW4384922260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.